164 related articles for article (PubMed ID: 15172050)
1. Interleukin-18 and the treatment of rheumatoid arthritis.
Dinarello CA
Rheum Dis Clin North Am; 2004 May; 30(2):417-34, ix. PubMed ID: 15172050
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience with inhibition of interleukin-6.
Choy E
Rheum Dis Clin North Am; 2004 May; 30(2):405-15, viii. PubMed ID: 15172049
[TBL] [Abstract][Full Text] [Related]
3. [Interleukin-18 and new drugs. Protective effect against tumor growth and infections].
Wollheim FA
Lakartidningen; 2000 Oct; 97(41):4604. PubMed ID: 11107747
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-18 and the pathogenesis of inflammatory diseases.
Dinarello CA
Semin Nephrol; 2007 Jan; 27(1):98-114. PubMed ID: 17336692
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-18: a therapeutic target in rheumatoid arthritis?
McInnes IB; Liew FY; Gracie JA
Arthritis Res Ther; 2005; 7(1):38-41. PubMed ID: 15642152
[TBL] [Abstract][Full Text] [Related]
6. Characterization of pristane-induced arthritis, a murine model of chronic disease: response to antirheumatic agents, expression of joint cytokines, and immunopathology.
Patten C; Bush K; Rioja I; Morgan R; Wooley P; Trill J; Life P
Arthritis Rheum; 2004 Oct; 50(10):3334-45. PubMed ID: 15476226
[TBL] [Abstract][Full Text] [Related]
7. Targeting IL-17 and Th17 cells in rheumatoid arthritis.
Sarkar S; Fox DA
Rheum Dis Clin North Am; 2010 May; 36(2):345-66. PubMed ID: 20510238
[TBL] [Abstract][Full Text] [Related]
8. Cytokine networks--towards new therapies for rheumatoid arthritis.
McInnes IB; Liew FY
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):31-9. PubMed ID: 16932625
[TBL] [Abstract][Full Text] [Related]
9. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis.
Bokarewa M; Lindblad S; Bokarew D; Tarkowski A
Arthritis Res Ther; 2005; 7(2):R349-58. PubMed ID: 15743483
[TBL] [Abstract][Full Text] [Related]
10. Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.
Furst DE
Clin Ther; 2004 Dec; 26(12):1960-75. PubMed ID: 15823761
[TBL] [Abstract][Full Text] [Related]
11. Cytokine inhibitors in rheumatoid arthritis and other autoimmune diseases.
Williams RO; Paleolog E; Feldmann M
Curr Opin Pharmacol; 2007 Aug; 7(4):412-7. PubMed ID: 17627887
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-1beta influences the effect of infliximab on temporomandibular joint pain in rheumatoid arthritis.
Kopp S; Alstergren P; Ernestam S; Nordahl S; Bratt J
Scand J Rheumatol; 2006; 35(3):182-8. PubMed ID: 16766364
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokine profiles of patients with elderly-onset rheumatoid arthritis: a comparison with younger-onset disease.
Chen DY; Hsieh TY; Chen YM; Hsieh CW; Lan JL; Lin FJ
Gerontology; 2009; 55(3):250-8. PubMed ID: 18849599
[TBL] [Abstract][Full Text] [Related]
14. Synovial tissue interleukin-18 expression and the response to treatment in patients with inflammatory arthritis.
Rooney T; Murphy E; Benito M; Roux-Lombard P; FitzGerald O; Dayer JM; Bresnihan B
Ann Rheum Dis; 2004 Nov; 63(11):1393-8. PubMed ID: 15479888
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 blockade suppresses autoimmune arthritis in mice by the inhibition of inflammatory Th17 responses.
Fujimoto M; Serada S; Mihara M; Uchiyama Y; Yoshida H; Koike N; Ohsugi Y; Nishikawa T; Ripley B; Kimura A; Kishimoto T; Naka T
Arthritis Rheum; 2008 Dec; 58(12):3710-9. PubMed ID: 19035481
[TBL] [Abstract][Full Text] [Related]
16. Biological agents targeting interleukin-18.
Jelusic M; Lukic IK; Batinic D
Drug News Perspect; 2007 Oct; 20(8):485-94. PubMed ID: 18080035
[TBL] [Abstract][Full Text] [Related]
17. Collagen-induced arthritis in mice: a major role for tumor necrosis factor-alpha.
Williams RO
Methods Mol Biol; 2007; 361():265-84. PubMed ID: 17172717
[TBL] [Abstract][Full Text] [Related]
18. The role of IL-1 and IL-1Ra in joint inflammation and cartilage degradation.
Jacques C; Gosset M; Berenbaum F; Gabay C
Vitam Horm; 2006; 74():371-403. PubMed ID: 17027524
[TBL] [Abstract][Full Text] [Related]
19. Autoimmune inflammation from the Th17 perspective.
Furuzawa-Carballeda J; Vargas-Rojas MI; Cabral AR
Autoimmun Rev; 2007 Jan; 6(3):169-75. PubMed ID: 17289553
[TBL] [Abstract][Full Text] [Related]
20. TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.
Horai R; Nakajima A; Habiro K; Kotani M; Nakae S; Matsuki T; Nambu A; Saijo S; Kotaki H; Sudo K; Okahara A; Tanioka H; Ikuse T; Ishii N; Schwartzberg PL; Abe R; Iwakura Y
J Clin Invest; 2004 Dec; 114(11):1603-11. PubMed ID: 15578092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
